Trial design and oversight.
INFECTIOUS DISEASES, ALLERGY
The study has a randomized, quadruple-masked (participants, care providers, investigators, and outcome assessors), crossover design comparing plerixafor with G-CSF, and it was conducted at the NIH-CC. The trial was investigator initiated and designed and was sponsored by the National Institute of Allergy and Infectious Diseases Division of Clinical Research. Additional details can be found in the 